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Influence of Tetracycline Phototoxicity on the Growth of Cultured 
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The phototoxic effect of 8 different commercial tet-
racycline derivatives with long-wave ultraviolet radia-
tion (UV A) on the growth pattern of normal human skin 
fibroblasts in culture was studied. Chlortetracycline and 
doxycycline both at a concentration of 50 J.LS/ml and 1.9 
J /cm2 of UV A resulted in total cell death with no recov-
ery during a 14-day observation period. Demethylchlor-
tetracycline also showed strong photosensitizing prop-
erties with an arrested cell division for 7 days followed 
by a recurrence of cell growth. The other tetracyclines 
tested under identical conditions had only weak or no 
phototoxic influence on cell growth. These experimental 
data correlate very well with clinical reports and com-
parative phototoxicity trials in humans. This experi-
mental method may thus be of value for predicting tet-
racycline phototoxicity in humans. 
It is well documented that the tetracyclines are able to induce 
lig h t reactions in human s kin and nails [1] . The incidence of 
skin photosensitivity following treatment with demethylchlor-
tetracycline (DMCT) has been reported to be especially high 
[1]. T o our knowledge there are no clinical reports about light-
induced side effects from minocycline. In 3 studies on tetracy-
cline phototoxic potential, human volunteers have been given 
one of the tetracycline derivatives prior to natural sunlight 
exposure and examined for abnormal reactions. Blank et al 
[2], comparing DMCT and doxycycline, t hus found 9/10 and 
2 /10 individuals, respectively, with abnormal reactions. Frost 
et a l [3), studying DMCT vs methacycline, found 12/13 and 1/ 
14, respectively, with phototoxic reaction s [3). The latter in-
vestigators, comparing doxycycline and minocycline, noted 11/ 
15 and 0/19, respectively, with abnormal reactions [4]. 
Different experimental models have a lso been used for study-
ing tetracycline phototoxicity. In a recent study, using a pho-
tohemolysis technique, we showed that DMCT and doxycycline 
had pronounced hemolytic properties [5]. Since human eryth-
rocytes are cells without nuclei we found it of interest to expand 
the studies to cultured human skin fibroblasts which are nu-
cleated cells in division. 
MATERIALS AND METHODS 
Drugs 
T he 8 com mercial tetracycl ine derivatives were provided by the 
fo llowing companies: DMCT, tetracycline, chlortetracycl ine, and min-
ocycline by Lederle Laboratories, Pearl River, New York; doxycycline, 
oxytetracycl ine, and methacycline by Pfizer, Brussels, B<.! lgium; and 
lymecycline by Farmitalia Carlo Erba, T iiby, Sweden. 
Basic Experimental Design 
Fibroblasts were obtained and cultured as described earlier (6]. Skin 
biopsies from 8 healthy males aged 13- 75 years (mean 48.7) were cut 
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into small pieces, and placed at the bottom of 25-cm2 plastic culture 
flasks (A/S Nunc, Denmark). T he flasks were turned upside down and 
5 ml medium was added. The biopsies were left uncovered with medium 
for 1- 1.5 h to ensure adhesion before the flasks were turned again to 
be left untouched during 10 days at 37"C for outgrowth. All medium 
components were obtained from Gibco, Chemoferm AB, Sweden. Min -
imum essential medium with Hanks' salts was supplemented with heat-
inactivated fetal calf serum (10%), L-glutamine (585 mg/liter), nones-
sent ial amino acid mixture (1 %), and gentamicin (100 mg/liter). During 
outgrowth medium was changed twice a week. Confluent cells were 
subcultivated by the use of 0.05% trypsin- 0.02% EDTA. 
For the experiments confluent cells from passages 1-6 were used. 
During irradiation of the flasks medium was replaced by drug dissolved 
in physiological saline adjusted to pH 7.2 with NaOH. Nonirradiated 
drug-exposed cell cultures were kept in the dark for equally long periods 
as controls. Controls that were neit her irradiated nor treated with drug 
were kept in the dark in physiologic saline. 
The cells were irradiated in the flasks at 10 em distance with 2.5-20 
min long-wave ultraviolet radiation (UVA) from 2 blacklight fluores-
cent tubes (Philips TLA 40 W /08) with an emission peak at 360 nm. 
A 3-mm window glass filter was inserted to eliminate wavelengths 
shorter than 320 nm. The output inside the flask at the level of the 
cells was 2.1 mW/cm2 in the UVA as measured with a PUVA-meter 
(Waldmann AG, Schwenningen, G.F.R.) . 
After irradiation the drug solut ion was poured off and the cells in 
each flask were t rypsinized, counted in a Biirker chamber, and subcul-
tivated into a t issue culture multiwell plate containing 12 wells with 
an area of 4.5 cm2 (Linbro, Linbro Scientific, Inc., Hamden, Connect-
icut). The initial cell density of a cont rol well was approximately 1.0 X 
106 cells per well. The cells were then left to grow and were counted on 
days 1, 3, 7, 10, 14, and sometimes 21 with 2 wells counted on each 
occasion. 
All experiments comparing different drugs were performed simulta-
neously with cells from one donor. 
Studies on Doxycycline 
Fibroblasts in the presence of doxycycline 5, 10, 25, and 50 1-'g/ ml 
were irradiated with 1.9 J /cm2 (15 min) ofUVA. In a second expenm~nt 
fibrobl asts in the presence of doxycycline 50 J.lgfml were irradiated w1th 
0.3, 0.6, 1.3, and 1.9 Jfcm2 of UVA (2.5, 5, 10, and 15 min). As control, 
cells with no drug added were irradiated with 2.5 J /cm2 of UVA (20 
min). 
Studies on the Phototoxic Potency of Eight Different Tetracycline 
Derivatives 
Fibroblasts in the presence of 50 1-'g/ml of each of the tetracycline 
derivatives were irradiated with 1.9 J /cm2 of UVA. T his experiment 
was repeated with fibroblasts from another donor. With DMCT alone 
the experiment was repeated on 4 different occasions. 
RESULTS 
Studies on Doxycycline 
A dose-response relationship concerning growth inhibit ion 
was obtained with increasing concentrations of doxycycline 
resulting in total cell death with 25 and 50 J.Lg/ml (Fig lA ). A 
dose-response curve was also obtained with a constant doxy-
cycline concen t rat ion (50 J.Lg/ml) but increasing doses of UV A 
with a total cell death at 1.9 J/cm2 (Fig 1B). UVA irradiation 
of 2.5 J/cm2 did not affect cell growth. 
Studies on the Phototoxic Potency of Eight Different 
Tetracycline Derivatives 
As can be seen from Fig 2, chlortetracycline and doxycycl ine 
addition both resulted in a cell number decreasing to almost 
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FIG 1. Cell growth pattern for fibroblasts treated with doxycyline 5, 
10, 25, and 50 1-'g/ml combined with UVA 1.9 J/cm2 (A) or doxycycline 
50 1-'g/ml combined with UVA 0.3, 0.6, 1.3, and 1.9 J/cm2 (B) on day 0 
compared to untreated cells. Cell density of control cells immediately 
after irradiation on day 0 is plotted as 100% and serves as baseline 
control for all curves in this experiment. 
zero on day 3 with no tendency to recovery during 14 days' 
observation. DMCT supplementation resulted in a temporary 
arrest in cell growth, during 7 days, whereafter normal cell 
growth recurred. The other tetracyclines tested had only weak 
or no phototoxic influence on cell growth at the concentration 
tested. A second experiment with all 8 derivatives, as well as 4 
experiments with DMCT alone, showed similar results. In no 
c.ase did tetracycline derivatives themselves, i.e., without UV A, 
affect cell growth. 
DISCUSSION 
Doxycycline and chlortetracycline followed by DMCT were 
the strongest photosensitizers in this study on normal human 
skin fibroblasts. The other derivatives did not significantly 
influence cell growth. These findings closely correlate with the 
results of Hasan et a! studying decrease of [3H ]thymidine 
incorporation into human lymphocytes [7). The correlation 
also. is fairly good between our results in fibroblasts and a 
recent in vitro study using photohemolysis [5). Investigations 
on dividing fibroblasts may constitute a more physiologic sys-
tem than the use of erythrocytes, which are devoid of nuclei 
and without the capacity to divide. This is also indicated by 
the lower and more physiologic UV A doses applied in the 
present study. It should also be pointed out that doxycycline 
affected cell growth in as low concentrations as 5-10 ,ug/ml 
which is in the same order of magnitude as the normal serum 
concentration in humans (2-4 ,ug/ml) [8). 
Does the phototoxic potency of the different tetracycline 
derivatives in cultured human skin fibroblasts parallel their 
clinical photosensitizing capacity in humans? DMCT is the 
drug most frequently occurring in scattered clinical reports [1) 
and also it had great sensitizing capacity in 2 comparative trials 
using human volunteers [2,3]. Chlortetracycline comes second 
concerning reported clinical photoreactions [1], but unfortu-
nately there are no comparative trials including this drug. 
Doxycycline (the most prescribed tetracycline in Sweden but 
rarely used in the United States) is the tetracycline most 
frequently causing photoreactions as reported to the Drug 
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FIG 2. Cell growth pattern for fibroblasts treated with oxytetracy-
cline, minocycline, tetracycline, methacycline, lymecycline, DMCT, 
chlortetracycline, and doxycycline 50 1-'g/ml and UVA 1.9 J/cm2 on day 
0 compared to untreated cells. For explanation see Fig 1. 
and Welfare [9) . This drug also has shown medium to strong 
photosensitizing capacity in comparative trials [2,4] . The other 
tetracycline derivatives, which demonstrated only weak pho-
totoxic properties in this study, are rarely reported clinically as 
sensitizers [1] and are negative or weak (minocycline and 
methacycline, respectively) phototoxic agents in existing com-
parative trials [3,4). 
There thus seems to be a good correlation between this 
experimental study and clinical conditions. 
We wish to thank Mrs. Kerstin Knutsson and Mrs. Karin Lundberg 
for skillful technical assistance. 
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